Scranton Richard 4
4 · Pacira Pharmaceuticals, Inc. · Filed Jun 6, 2018
Insider Transaction Report
Form 4
Scranton Richard
Chief Scientific Officer
Transactions
- Sale
Common Stock
2018-06-04$33.02/sh−1,367$45,138→ 12,226 total
Footnotes (1)
- [F1]Represents shares sold by the reporting person to cover tax obligations upon the vesting of restricted stock units.